Sorrento Therapeutics

SRNE

OTCHealth Care

Income Statement

Total Revenue$60.1M

Gross Profit$26.29M

Operating Income$-396.94M

EBITDA$-344.64M

EBIT$-367.49M

Pre-tax Income$-552.8M

Net Income$-380.85M

Cash Equivalent$69.75M

Total Debt$516.52M

Book Value$-197.96M

Book Value Per Share-0.36

Return on Equity (ROE)-544.22%

Return on Assets (ROA)-121.15%

Return on Invested Capital (ROI)-193.54%

Net Profit Margin-912.10%

Current Ratio0.29

Quick Ratio0.24

Long-Term Debt / Equity1.41